Urine test may shorten bladder cancer treatment without sacrificing results
NCT ID NCT07475403
First seen Mar 16, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study looks at whether a urine test for tumor DNA can help doctors decide how long to give immunotherapy to people with a severe, hard-to-treat type of bladder cancer. About 53 adults with very-high-risk non-muscle-invasive bladder cancer that cannot be fully removed by surgery will receive immunotherapy. If the urine test and other checks show the cancer is gone, treatment may be stopped earlier than usual. The goal is to see if this shorter, guided treatment keeps the cancer from coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Hospital of Tianjin Medical University
RECRUITINGTianjin, 300000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.